63 related articles for article (PubMed ID: 6437952)
1. [In-vitro activity of new beta-lactam antibiotics. Testing resistant enterobacteria and pseudomonas aeruginosa strains].
Rosenthal E
Fortschr Med; 1984 Nov; 102(41):1051-2. PubMed ID: 6437952
[TBL] [Abstract][Full Text] [Related]
2. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
3. [Activity of new beta-lactam antibiotics].
Cullmann W; Stieglitz M
Fortschr Med; 1982 May; 100(19):888-92. PubMed ID: 6807788
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
Wundt W; Lange KP; Baumgärtner M
Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
[TBL] [Abstract][Full Text] [Related]
6. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
Thabaut A; Durosoir JL; Meyran M
Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivity to antibiotics of Pseudomonas aeruginosa isolated from patients in the years 1986-1988].
Gościniak G; Dolna I; Ruczkowska J; Fleischer M
Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1028-32. PubMed ID: 2517806
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
Patzer J; Gieburowska R; Dzierzanowska D
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
[TBL] [Abstract][Full Text] [Related]
9. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)].
Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A
Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
[TBL] [Abstract][Full Text] [Related]
11. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
Cluzel M; Chanal M; Sirot J; Cluzel R
Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance].
Bert F; Briaud I; Branger C; Lambert-Zechovsky N
Pathol Biol (Paris); 1996 May; 44(5):329-32. PubMed ID: 8758469
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
Høiby N; Bremmelgaard A; Schouenborg P
Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae.
Thabaut A; Durosoir JL; Saliou P
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():123-5. PubMed ID: 19810174
[TBL] [Abstract][Full Text] [Related]
16. Simple method to determine beta-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test.
Vedel G
J Antimicrob Chemother; 2005 Oct; 56(4):657-64. PubMed ID: 16144872
[TBL] [Abstract][Full Text] [Related]
17. Comparative susceptibilities of 40 strains of Pseudomonas aeruginosa to 10 antipseudomonal antimicrobial agents.
Davidson S; Lipshitz M; Bogokowski B; Rubinstein E
Isr J Med Sci; 1982 Aug; 18(8):859-62. PubMed ID: 6811501
[TBL] [Abstract][Full Text] [Related]
18. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Ciofu O; Giwercman B; Pedersen SS; Høiby N
APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
[TBL] [Abstract][Full Text] [Related]
19. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
20. Effect of beta-lactam antibiotics on the in vitro development of resistance in Pseudomonas aeruginosa.
Carsenti-Etesse H; Cavallo JD; Roger PM; Ziha-Zarifi I; Plesiat P; Garrabe E; Dellamonica P
Chirurgia (Bucur); 2002; 97(2):151-9. PubMed ID: 12731225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
